Why the drugs my cancer patients rely on are at risk

As a physician who specializes in treating myeloma, I worry that the Biden administration may soon inadvertently snuff out new therapies for myeloma and cancer in general. The Centers for Medicare& Medicaid Services— the agency that oversees the government's two largest insurance programs— is deciding how to implement this legislation, which directs the…